Your browser doesn't support javascript.
loading
Effects of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients: A prospective study.
Ohara, Makoto; Nagaike, Hiroe; Fujikawa, Tomoki; Kohata, Yo; Ogawa, Maiho; Omachi, Takemasa; Sasajima, Risa; Chiba, Hirotoshi; Ara, Toshimasa; Sugawara, Ayuka; Hiromura, Munenori; Terasaki, Michishige; Mori, Yusaku; Fukui, Tomoyasu; Hirano, Tsutomu; Yokoyama, Hiroki; Yamagishi, Sho-Ichi.
Afiliação
  • Ohara M; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan. Electronic address: s6018@nms.ac.jp.
  • Nagaike H; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Fujikawa T; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Kohata Y; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Ogawa M; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Omachi T; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Sasajima R; Department of Internal Medicine, Jiyugaoka Medical Clinic, Hokkaido, Japan.
  • Chiba H; Department of Internal Medicine, Jiyugaoka Medical Clinic, Hokkaido, Japan.
  • Ara T; Department of Internal Medicine, Jiyugaoka Medical Clinic, Hokkaido, Japan.
  • Sugawara A; Department of Internal Medicine, Jiyugaoka Medical Clinic, Hokkaido, Japan.
  • Hiromura M; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Terasaki M; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Mori Y; Division of Diabetes, Metabolism, and Endocrinology, Anti-glycation Research Section, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Fukui T; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Hirano T; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan; Diabetes Center, Ebina General Hospital, Kanagawa, Japan.
  • Yokoyama H; Department of Internal Medicine, Jiyugaoka Medical Clinic, Hokkaido, Japan.
  • Yamagishi SI; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Diabetes Res Clin Pract ; 179: 108999, 2021 Sep.
Article em En | MEDLINE | ID: mdl-34390762
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: Diabetes Res Clin Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de publicação: Irlanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: Diabetes Res Clin Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de publicação: Irlanda